AKT1 and cancer: The landscape of cancer resistance mechanisms is significantly influenced by the reconfiguration of key cellular signaling pathways, notably the mitogen-activated protein kinase (MAPK) and the phosphoinositide 3-kinase–protein kinase B/Akt (PI3K-PKB/Akt) pathways[9,10].